We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
-26.2%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
AUM
$118M
AUM Growth
-$54.5M
Cap. Flow
-$8.91M
Cap. Flow %
-7.58%
Top 10 Hldgs %
100%
Holding
11
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$8.91M

Sector Composition

Rank Sector Weight
1 Healthcare 97.14%
2 Financials 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMVP icon
1
PMV Pharmaceuticals
PMVP
$59.2M
$33.3M 28.32%
2,336,909
ME
2
DELISTED
23andMe Holding Co
ME
$25.4M 21.61%
512,156
FHTX icon
3
Foghorn Therapeutics
FHTX
$266M
$17.2M 14.59%
1,261,261
ALEC icon
4
Alector
ALEC
$168M
$9.97M 8.48%
980,894
NGM
5
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$9.57M 8.14%
746,674
RAPT
6
DELISTED
RAPT Therapeutics
RAPT
$7.9M 6.72%
54,113
TNYA icon
7
Tenaya Therapeutics
TNYA
$161M
$5.16M 4.38%
915,705
FFBC icon
8
First Financial Bancorp
FFBC
$3.55B
$3.37M 2.86%
173,576
ORIC icon
9
Oric Pharmaceuticals
ORIC
$1.15B
$3.35M 2.85%
747,550
SRZN icon
10
Surrozen
SRZN
$258M
$2.41M 2.05%
53,531
COIN icon
11
Coinbase
COIN
$38.6B
-46,922
Closed -$8.91M

Similar funds

Euclidean Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Euclidean Capital held 11 positions worth $118M, down 32% from $172M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital withdrew a net $8.91M in Q2 2022, closing 1 position. Its most notable exit was Coinbase, an estimated $8.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 92% a quarter earlier, followed by Financials.

  • Euclidean Capital fully exited Coinbase in Q2 2022, selling an estimated $8.91M.
  • Euclidean Capital's ten largest holdings make up 100% of its $118M portfolio in Q2 2022.
  • Euclidean Capital opened 0 new positions and closed 1 in Q2 2022.
  • Euclidean Capital's portfolio value fell 32% quarter-over-quarter to $118M.

Based on Euclidean Capital's 13F filing for Q2 2022, filed 15 Aug 2022.